Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease
This study is currently recruiting participants.
Verified February 2013 by Genzyme
Study NCT01574326   Information provided by Genzyme

First Received on April 6, 2012.   Last Updated on February 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperphosphatemia
Chronic Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Metabolic Diseases
Phosphorus Metabolism Disorders
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
sevelamer carbonate
Placebo
Additional drug interventions recognized in this trial
Sevelamer
More general drug interventions related to this trial
Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Genzyme


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services